IM Cannabis (IMCC) Net Income Growth (3y) (2023 - 2026)
IM Cannabis (IMCC) Net Income Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 51.28% |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -62.58% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | -17.90% |
| 10 | IM Cannabis | 530,175.99 | -201,946.53 | 1.03 Mn | 67.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.60% |
| Dec 31, 2025 | -30.63% |
| Sep 30, 2025 | -69.42% |
| Jun 30, 2025 | 78.90% |
| Mar 31, 2025 | -65.18% |
| Dec 31, 2024 | 6.37% |
| Sep 30, 2024 | -43.90% |
| Jun 30, 2024 | 37.69% |
| Mar 31, 2024 | 6.24% |
| Dec 31, 2023 | 55.20% |
| Sep 30, 2023 | -147.67% |
| Mar 31, 2023 | -32.90% |